General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Novo Nordisk Inc.(SIGNIFICANT), Amgen Inc.(MODEST), Merck & Co., Inc. ( Ended November of 2020 )(MODEST), Medtronic(SIGNIFICANT), Bayer Healthcare Pharmaceuticals(SIGNIFICANT)

View Full Disclosure